NEW TOREX MINT

Oral Liquids

NEW TOREX MINT

PACKING:
144x100ml

COMPOSITION:
Each 5 ml contains:
Levocetirizine Dihydrochloride
I.P.
5 mg
Ambroxol hydrochloride
I.P.
30 mg
In a flavoured mentholated syrupy base
 
 
Colour: Tartrazine and brilliant blue FCF
 
 
 
DESCRIPTION:
Ambroxol is the metabolite of bromhexine and a mucolytic agent. Ambroxol acts as secretolytic agent used in the treatment of respiratory diseases associated with viscid or excessive mucus. Levocetirizine dihydrochloride is the R enantiomer of cetirizine hydrochloride, a racemic compound with antihistaminic properties.
 
MECHANISM OF ACTION:
Ambroxol facilitates mucociliary clearance by intensifying the motion of the cilia present on the ciliated respiratory epithelium. Levocetirizine, the active enantiomer of cetirizine, is an antihistamine; its principal effects are mediated via selective inhibition of H1 receptors. In vitro binding studies revealed that levocetirizine has an affinity for the human H1-receptor 2-fold higher than that of cetirizine (Ki = 3 nmol/L vs.6 nmol/L, respectively).
 
INDICATIONS:
Indicated for the treatment of whooping cough, post-surgical cough, dry cough, smokers cough, chronic cough.
 
CONTRAINDICATIONS:
Hypersensitivity to any of the ingredients of product.
 
DOSAGE:
As directed by the physician.
 
STORAGE:
Store in cool and dry place. Recap the bottle tightly after use.
 
SHAKE WELL BEFORE USE
 
PRESENTATION:
100 ml
 
0108906044105430, 0118906044105437, 0128906044105434
https://getinfoon.net/